August 5, 2015
Applied Clinical Trials: TransCelerate’s Data Transparency Initiative
Explore
News
July 31, 2015
Health IT Security: How Does Data De-Identification Affect Clinical Research?
Explore
July 30, 2015
CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia
The Clinical Data Interchange Standards Consortium (CDISC), the Critical Path Institute (C-Path), and TransCelerate BioPharma Inc. announce that Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia have been published for use and accessible on the CDISC website.
Explore
June 2, 2015
Authors Representing TransCelerate BioPharma Inc. Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting
A group of nine authors involved with TransCelerate BioPharma Inc. were honored with a Global Inspire Award at DIA’s 2015 Annual Meeting. The recipients of the Author(s) of the Year Award published “Defining a Central Monitoring Capability: Sharing the Experience of TransCelerate BioPharma’s Approach, Part 1,” in DIA’s official, scientific, peer-reviewed journal, Therapeutic Innovation &…
Explore
May 5, 2015
Applied Clinical Trials: TransCelerate’s Placebo and SOC Data Sharing Initiative
Explore
May 5, 2015
Clinical Leader: TransCelerate Moves Forward With Electronic Label Initiative
Explore
April 27, 2015
Outsourcing-Pharma.com: TransCelerate CEO, leaders offer update on industry group’s activities
Explore
April 25, 2015
Applied Clinical Trials: TransCelerate’s eLabeling Initiative
Explore
April 22, 2015
Data De-identification & Anonymization White Paper From the Data Transparency Initiative
Review our Model Approach to Data De-identification and Anonymization of Individual Patient Data in Clinical Studies
Explore
April 21, 2015
Training Module From the SQT Initiative
Review our Principal Investigator Oversight Program to support improved quality, enhanced patient safety and efficiency of study startup.
Explore